Q1 FY27 results filed — revenue ₹45 Cr (+4.0% YoY), PAT ₹2 Cr (−13.0% YoY)BSE filing · raw filing ↗
10 Aug 2026
⚑ Result
Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for Considering And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June, 2026BSE filing · raw filing ↗
4 Aug 2026
⚑ Filing
Copy of Newspaper PublicationNSE filing · raw filing ↗
Commencement of commercial production/operationsNSE filing · raw filing ↗
21 May 2026
⚑ Filing
Disclosure under SEBI Takeover RegulationsNSE filing · raw filing ↗
20 May 2026
⚑ Filing
Disclosure under SEBI Takeover RegulationsNSE filing · raw filing ↗
Ex-date 24 Mar 2026
⚑ Corp action
bonus — 1:1NSE filing · record 24 Mar 2026
Ex-date 15 Jul 2025
⚑ Corp action
rights_issue — 2:23NSE filing · record 15 Jul 2025
Ex-date 20 Sep 2019
⚑ Corp action
Dividend — ₹0.50 per shareNSE filing
Ex-date 18 Sep 2018
⚑ Corp action
Dividend — ₹0.50 per shareNSE filing
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
